Showing results (81-90 of 143) with videos related to
Sort By:
Pageof 15
Journal of Palliative Medicine|September 15, 2016
End-of-Life Care in Patients with Metastatic Lung Cancer Harboring Epidermal Growth Factor Receptor MutationsJessica R Bauman, Zofia Piotrowska, Alona Muzikansky, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2015
The Allelic Context of the C797S Mutation Acquired upon Treatment with Third-Generation EGFR Inhibitors Impacts Sensitivity to Subsequent Treatment StrategiesMatthew J Niederst, Haichuan Hu, Hillary E Mulvey, et al.International Journal of Radiation Oncology, Biology, Physics|November 22, 2024
Phase 2 Trial of Consolidative Stereotactic Body Radiation Therapy in Patients With Metastatic Oncogene-driven Non-small Cell Lung Carcinoma Treated With Tyrosine Kinase InhibitorsFlorence K Keane, Beow Y Yeap, Melin J Khandekar, et al.Carbohydrate Research|August 4, 2026
The complete structure of lipid a from Rhizobium giardinii bv. giardinii CAS 24 the bacterial endophyte of white Spanish broom (Chamaecytisus albus)Adam Choma, Iwona Komaniecka, Piotr Koper, et al.Journal of Hazardous Materials|March 6, 2022
High concentrations of HgS, MeHg and toxic gas emissions in thermally affected waste dumps from hard coal mining in PolandÁdám Nádudvari, Jerzy Cabała, Leszek Marynowski, et al.Clinical Lung Cancer|February 21, 2021
Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at ProgressionMaya N White, Zofia Piotrowska, Kevin Stirling, et al.Cancer Research|May 23, 2019
Patient-Specific Tumor Growth Trajectories Determine Persistent and Resistant Cancer Cell Populations during Treatment with Targeted TherapiesClemens Grassberger, David McClatchy, Changran Geng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2018
EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung AdenocarcinomasSusan E Jorge, Antonio R Lucena-Araujo, Hiroyuki Yasuda, et al.Lung Cancer (Amsterdam, Netherlands)|November 30, 2024
Alectinib combined with cobimetinib in ALK-Rearranged lung Cancer: A phase IB studyIbiayi Dagogo-Jack, Alissa J Cooper, Bruce E Johnson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2024
Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS OutcomesCatherine B Meador, Subba R Digumarthy, Beow Y Yeap, et al.Pageof 15